Seqens Seqens

X

CAS 119018-29-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 119018-29-0
Also known as: 119018-29-0, Glimepiride sulfonamide, Glimepiride related compound b, Glimepiride sulphonamide, 4-ethyl-3-methyl-5-oxo-n-[2-(4-sulfamoylphenyl)ethyl]-2h-pyrrole-1-carboxamide, 612913u5l6
Molecular Formula
C16H21N3O4S
Molecular Weight
351.4  g/mol
InChI Key
AJEMFZRCUKJSES-UHFFFAOYSA-N
FDA UNII
612913U5L6

1 2D Structure

CAS 119018-29-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-ethyl-3-methyl-5-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-2H-pyrrole-1-carboxamide
2.1.2 InChI
InChI=1S/C16H21N3O4S/c1-3-14-11(2)10-19(15(14)20)16(21)18-9-8-12-4-6-13(7-5-12)24(17,22)23/h4-7H,3,8-10H2,1-2H3,(H,18,21)(H2,17,22,23)
2.1.3 InChI Key
AJEMFZRCUKJSES-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)C
2.2 Other Identifiers
2.2.1 UNII
612913U5L6
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 119018-29-0

2. Glimepiride Sulfonamide

3. Glimepiride Related Compound B

4. Glimepiride Sulphonamide

5. 4-ethyl-3-methyl-5-oxo-n-[2-(4-sulfamoylphenyl)ethyl]-2h-pyrrole-1-carboxamide

6. 612913u5l6

7. 3-ethyl-4-methyl-2-oxo-n-[2-(4-sulfamoylphenyl)ethyl]-2,5-dihydro-1h-pyrrole-1-carboxamide

8. 4-(2-((3-ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide

9. 3-ethyl-4-methyl-2-oxo-n-[2-(4-sulphamoylphenyl)ethyl]-2,3-dihydro-1h-pyrrole-1-carboxamide (glimepiride Sulphonamide)

10. Unii-612913u5l6

11. Ec 411-850-0

12. Oprea1_386350

13. Schembl14371709

14. Dtxsid20152297

15. Amy33442

16. Bcp10472

17. Usp Glimepiride Related Compound B

18. Mfcd02955393

19. Stk993693

20. Zinc21298457

21. Akos005657772

22. Ac-1493

23. Cs-w022064

24. Gs-3185

25. 3-ethyl-4-methyl-2-oxo-n-(4-sulfamoylphenethyl)-2,5-dihydro-1h-pyrrole-1-carboxamide

26. 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)

27. 3-ethyl-4-methyl-2-oxo-2,5-dihydro-pyrrole-1-carboxylic Acid [2-(4-sulfamoyl-phenyl)-ethyl]-amide

28. N-[2-[4-(aminosulfonyl)phenyl]ethyl]-3-ethyl-2,5-dihydro-4-methyl-2-oxo-1h-pyrrole-1-carboxamide

29. Ft-0642911

30. Glimepiride Impurity B [ep Impurity]

31. C71616

32. Glimepiride Related Compound B [usp-rs]

33. 018e290

34. A804150

35. J-004054

36. Glimepiride Related Compound B [usp Impurity]

37. Q27263274

38. 4-[2-(2-oxo-3-ethyl-4-methyl-3-pyrroline-1-ylcarbonylamino)ethyl]benzenesulfonamide

39. 4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrrolidine-1- Carboxamido)ethyl]benzenesulfonamide

40. 4-[2-[(3-ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl] Benzenesulfonamide

41. 1h-pyrrole-1-carboxamide, N-(2-(4-(aminosulfonyl)phenyl)ethyl)-3-ethyl-2,5-dihydro-4-methyl-2-oxo

42. 1h-pyrrole-1-carboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-3-ethyl-2,5-dihydro-4-methyl-2-oxo-

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 351.4 g/mol
Molecular Formula C16H21N3O4S
XLogP31.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass351.12527733 g/mol
Monoisotopic Mass351.12527733 g/mol
Topological Polar Surface Area118 Ų
Heavy Atom Count24
Formal Charge0
Complexity628
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
119018-29-0
Glimepiride
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Se...
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Semi finish formulations & Intermediate and also has a GMP certified Manufacturing facility for Phytochemicals / Herbal extract and Enzymes through our associates.
Zeon Pharma Industries India Pvt Ltd Company Banner

Cophex 2024

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
119018-29-0
Glimepiride
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutica...
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutical APIs & Fine Chemicals. We excel in Contract Manufacturing, covering a wide spectrum of intermediates, including advance intermediates, cGMP, & non-GMP intermediates. We represent GMP and WHO-certified manufacturers of APIs & advanced intermediates, offering Distribution & Agency services with rigorous selection processes & regular audits to guarantee top-quality products. Moreover, our global Strategic Sourcing capabilities provide high-quality ingredients & performance chemicals to the Pharmaceuticals & Specialty Chemical Industries.
Sigmak Lifesciences CB

Cophex 2024

Not Confirmed

envelop Contact Supplier
Flag China
Digital Content Digital Content
URL Supplier Web Content
119018-29-0
Glimepiride
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY